Research Article

Cellular and Molecular Life Sciences

, Volume 65, Issue 4, pp 656-666

Regulation of turnover of tumor suppressor p53 and cell growth by E6-AP, a ubiquitin protein ligase mutated in Angelman mental retardation syndrome

  • A. MishraAffiliated withCellular and Molecular Neuroscience Laboratory, National Brain Research Centre
  • , N. R. JanaAffiliated withCellular and Molecular Neuroscience Laboratory, National Brain Research Centre Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


E6-AP is a founding member of HECT (homologous to E6-AP C terminus) domain subfamily of E3 ubiquitin ligases. It degrades tumor suppressor p53 in association with the E6 oncoprotein of the human papilloma virus. However, there are conflicting reports on its role in the degradation of p53 in the absence of E6 oncoprotein. Here, we studied the role of E6-AP in regulation of p53 in mouse neuro 2a cells. Overexpression of E6-AP in neuro 2a cells increased the ubiquitylation and degradation of p53, which could be prevented upon deletion of HECT domain. E6-AP also directly ubiquitylated p53 in an in vitro ubiquitylation assay. Partial knockdown of E6-AP increased the levels of p53 and p53-dependent transcription. Partial knockdown also increased neuronal cell death, which may be mediated partly via p53. Our result suggests that E6-AP not only enhances the degradation of p53 but also regulates the neuronal cell growth.


E6-AP p53 Angelman syndrome transcription cell growth apoptosis